The EPS projection of Accenture plc. (NYSE:ACN) for quarter ended 2016-11-30 is $1.47. Last week, the projection for EPS was $1.47 against target of $1.47, a month earlier. While 2-months ago, this projection was $1.47 versus forecast of $1.47a quarter months earlier, posting a deviation of 0%.
Accenture plc. (NYSE:ACN) posted that 18 days earlier, the share price was revised 5 times on upside. In addition, negative revisions were 2.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 6 and 6. While in last 120 and 90 days, positive revisions were 5, and 5, correspondingly.
The per-share earnings downgrade for Accenture plc. (NYSE:ACN) in the preceding 30 and 120 were 3 and 3. While in 60 and 90 days were 3, and 3, in that order.
Accenture plc. (NYSE:ACN) EPS target was $1.47 for the quarter closed 3. It was based on 12 calls. As on 2016-06-23 the EPS was $1.41. The change was $0.01, posting a deviation of 0.71%. The price projections gave a standard deviation of 0.02.
Quarterly Sales Estimates
Accenture plc. (NYSE:ACN) sales prediction for the fiscal 2018 stands at $9481.645 and the median estimate is at $9478.305. Almost 4 analysts gave sales target.
Among this, the highest sales estimate is $9521.07 while the lowest target is $9448.9 showing standard deviation of 30.213%.
As many as 4 analysts have positive sales targets revision while 4 reduced sales estimates, posting a deviation of 0%.
Last month, 4 experts have positive sales number revision. Also, 4 research groups lowered the sales projections, posting a deviation of -0.039%.
A quarter ago, 4 hiked sales target and 4 reduced sales forecast, posting a deviation of -0.039%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...